Impact of hepatitis C infection on outcomes after heart transplantation

Transplantation

Volumn 88, Issue 9, 2009, Pages 1137-1141

  Fong, Tse Ling ^a   Hou, Linda ^a   Hutchinson, Ian V ^b   Cicciarelli, James C ^a,b   Cho, Yong W ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b National Institute of Transplantation Los Angeles   (United States)

Author keywords

Heart; Hepatitis C.; Transplant

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOSPORIN A; DACLIZUMAB; HEPATITIS C ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CAUSE OF DEATH; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HEART TRANSPLANTATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL RATE;

CREATININE; DIABETES MELLITUS; GRAFT REJECTION; HEART TRANSPLANTATION; HEPATITIS C; HUMANS; INCIDENCE; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 72949088165     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181bd3e59     Document Type: Article

References (31)

1. Fagiuoli S, Minniti F, Pevere S, et al. HBV and HCV infections in heart transplant recipients. J Heart Lung Transplant 2001; 20: 718.
2. Cadranel JF, Di Martino V, Dorent R, et al. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: Results of a prospective, double blind, placebo-randomized study. Transplantation 2003; 75: 977.
3. Kroes AC, de Man RA, Niesters HG, et al. Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only. J Hepatol 1994; 21: 1113.
4. Hayashi PH, Fernando L, Schuch DR, et al. Seronegative hepatitis C virus liver failure following transplantation of a cadaveric heart. West J Med 1994; 160: 368.
5. Lim HL, Lau GK, Davis GL, et al. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994; 106: 248.
6. Delgado J, Muñoz de Busstillo EM, Ibarrola C, et al. Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: Is aza-thioprine a contributory factor? J Heart Lung Transplant 1999; 18: 607.
7. Ong JP, Barnes DS, Younossi ZM, et al. Outcome of de novo hepatitis C virus infection in heart transplant recipients. Hepatology 1999; 30: 1293.
8. Haji SA, Starling RC, Avery RK, et al. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant 2004; 23: 277.
9. Gasink LB, Blumberg EA, Localio AR, et al. Hepatitis C virus seropos-itivity in organ donors and survival in heart transplant recipients. JAMA 2006; 296: 1843.
10. Lake KD, Smith CI, Milfred-La Forest SK, et al. Outcomes of hepatitis C positive (HCV+) heart transplant recipients. Transplant Proc 1997; 29: 581.
11. Castella M, Tenderich G, Koerner M, et al. Outcome of heart transplantation in patients previously infected with hepatitis C virus. J Heart Lung Transplant 2001; 20: 595.
12. Milfred SK, Lake KD, Anderson DJ, et al. Practices of cardiothoracic transplant centers regarding hepatitis C-seropositive candidates and donors. Transplantation 1994; 57: 568.
13. Lake KD, Smith CI, La Forest SK, et al. Policies regarding the transplantation of hepatitis C-positive candidates and donor organs. J Heart Lung Transplant 1997; 16: 917.
14. Fabrizi F, Martin P, Dixit V, et al. Hepatitis C virus antibody status and survival after renal transplantation: Meta analysis of observational studies. Am J Transplant 2005; 5: 1452.
15. Terrault NA, Adey DB. The kidney transplant recipient with hepatitis C infection: Pre-and posttransplant treatment. Clin J Am Soc Nephrol 2007; 2: 563.
16. Honaker MR, Stratta RJ, Lo A, et al. Impact of hepatitis C virus status in pancreas transplantation: A case controlled study. Clin Transplant 2002; 16: 243.
17. Barr ML, Bourge RC, Orens JB, et al. Thoracic organ transplantation in the United States, 1994-2003. Am J Transplant 2005; 5: 934.
18. Orens JB, Shearon TH, Freudenburger RS, et al. Thoracic organ transplantation in the United States, 1995-2004. Am J Transplant 2006; 6:1188.
19. Batty DS Jr, Swanson SJ, Kirk AD, et al. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: Associated factors and patient survival. Am J Transplant 2001; 1: 179.
20. Pereira BJ, Natov SN, Bouthot BA, et al; the New England Organ Bank Hepatitis C Study Group. Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease. Kidney Int 1998; 53:1374.
21. Ramos EL, Kasiske BL, Alexander SR, et al. The evaluation of candidates for renal transplantation. The current practice of U.S. transplant centers. Transplantation1994; 57: 490.
22. Fong TL, Valinluck B, Govindarajan S, et al. Effects of prednisone therapy on aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196.
23. Mas V, Alvarellos T, Chiurchiu C, et al. Hepatitis C virus infection after renal transplantation: Viral load and outcome. Transplant Proc 2001; 33: 1791.
24. Kamar N, Rostaing L, Selves J, et al. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 2005; 5: 1704.
25. Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes melli-tus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732.
26. Fabrizio F, Martin P, Dixit V, et al. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: Meta-analysis of clinical studies. Am J Transplant 2005; 5: 2433.
27. Agnello V, De Rosa F. Extrahepatic disease manifestations of HCV infection: Some current issues. J Hepatol 2004; 40: 341.
28. Gournay J, Ferrell LD, Roberts JP, et al. Cryoglobulinemia presenting after liver transplantation. Gastroenterology 1996; 110: 265.
29. Taniguchi H, Kato N, Otsuka M, et al. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J Med Virol2004; 2: 52.
30. Stoica SC, Cafferty F, Pauriah M, et al. The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. J Heart Lung Transplant 2006; 25: 420.
31. Burton JR Jr, Rosen HR. Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transpl 2006; 12: S38.